Literature DB >> 16008407

Stimulatory and inhibitory effects of alkyl bromide surfactants on beta-amyloid fibrillogenesis.

Raimon Sabaté1, Joan Estelrich.   

Abstract

Beta-amyloid peptide (Abeta), in fibrillar form, is the primary constituent of senile plaques, a defining feature of Alzheimer's disease. In solution assays, fibril formation exhibits a lag time, interpreted as a nucleation/condensation-dependent process. The kinetics of fibrillogenesis is controlled by two key parameters: nucleation and elongation rate constants. We characterized the time course of Abeta fibril formation by measuring the scattering caused by peptide aggregates. We report here the interaction of Abeta with three alkylammonium bromides (dodecyl, tetradecyl, and hexadecyl) at supra- and submicellar concentrations and their influence on the kinetic constants. We observed a dual behavior: surfactants promoted or retarded fibril formation in a concentration-dependent manner. Below a determined surfactant concentration (close to the corresponding critical micellar concentration in medium without peptide), surfactants favor aggregation, presumably by means of electrostatic interactions that destabilize the native conformation. Beyond such concentration, the stabilizing effects of the monomer predominate. As a general rule, surfactants delay but do not completely inhibit aggregation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008407     DOI: 10.1021/la050472x

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  6 in total

1.  Lysophospholipid-containing membranes modulate the fibril formation of the repeat domain of a human functional amyloid, pmel17.

Authors:  Zhiping Jiang; Jennifer C Lee
Journal:  J Mol Biol       Date:  2014-10-14       Impact factor: 5.469

2.  True and apparent inhibition of amyloid fibril formation.

Authors:  Pedro M Martins
Journal:  Prion       Date:  2012-12-11       Impact factor: 3.931

3.  Phenol red interacts with the protofibril-like oligomers of an amyloidogenic hexapeptide NFGAIL through both hydrophobic and aromatic contacts.

Authors:  Chun Wu; Hongxing Lei; Zhixiang Wang; Wei Zhang; Yong Duan
Journal:  Biophys J       Date:  2006-08-25       Impact factor: 4.033

Review 4.  Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

Authors:  Vijayaraghavan Rangachari; Dexter N Dean; Pratip Rana; Ashwin Vaidya; Preetam Ghosh
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-09       Impact factor: 3.747

5.  Inhibition of beta-amyloid(1-40) Peptide Aggregation and Neurotoxicity by Citrate.

Authors:  Yong Hoon Park; Young-Jin Kim; Il Hong Son; Hyun Duk Yang
Journal:  Korean J Physiol Pharmacol       Date:  2009-08-31       Impact factor: 2.016

6.  Potential applications of magnetic particles to detect and treat Alzheimer's disease.

Authors:  Maria Antònia Busquets; Raimon Sabaté; Joan Estelrich
Journal:  Nanoscale Res Lett       Date:  2014-10-01       Impact factor: 4.703

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.